Ilyang PharmaceuticalLtd (KOSE:A007575) - Stock Price, News & Analysis

A007575 Stock Overview

Operates as a pharmaceutical company primarily in South Korea. More details

A007575 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	1/6

Risk Analysis

Dividend of 1.35% is not well covered by earnings or free cash flows

Earnings have declined by 12% per year over past 5 years

Ilyang Pharmaceutical Co.,Ltd Competitors

Jeil PharmaceuticalLtd

KOSE:A271980

₩184.8b

HANDOK

KOSE:A002390

₩172.5b

CTCBIO

KOSDAQ:A060590

₩167.8b

Kolon Life Science

KOSDAQ:A102940

₩221.1b

Price History & Performance

Summary of all time highs, changes and price drops for Ilyang PharmaceuticalLtd
Historical stock prices
Current Share Price	₩10,000.00
52 Week High	₩19,400.00
52 Week Low	₩9,470.00
Beta	-0.43
11 Month Change	-15.97%
3 Month Change	-21.14%
1 Year Change	-38.65%
33 Year Change	-61.83%
5 Year Change	-40.12%
Change since IPO	17.65%

Recent updates

Shareholder Returns

	A007575	KR Pharmaceuticals	KR Market
7D	-5.7%	-3.1%	2.9%
1Y	-38.7%	4.8%	-2.8%

Return vs Industry: A007575 underperformed the KR Pharmaceuticals industry which returned 4.8% over the past year.

Return vs Market: A007575 underperformed the KR Market which returned -2.8% over the past year.

Price Volatility

Is A007575's price volatile compared to industry and market?
A007575 volatility
A007575 Average Weekly Movement	3.2%
Pharmaceuticals Industry Average Movement	5.2%
Market Average Movement	5.6%
10% most volatile stocks in KR Market	11.6%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A007575 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A007575's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1946	535	Dong-Yeon Kim	www.ilyang.co.kr

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.

Ilyang Pharmaceutical Co.,Ltd Fundamentals Summary

How do Ilyang PharmaceuticalLtd's earnings and revenue compare to its market cap?
A007575 fundamental statistics
Market cap	₩199.23b
Earnings (TTM)	-₩737.67m
Revenue (TTM)	₩364.56b

0.6x

P/S Ratio

-272.0x

P/E Ratio

Is A007575 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A007575 income statement (TTM)
Revenue	₩364.56b
Cost of Revenue	₩168.46b
Gross Profit	₩196.11b
Other Expenses	₩196.84b
Earnings	-₩737.67m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-40.95
Gross Margin	53.79%
Net Profit Margin	-0.20%
Debt/Equity Ratio	44.8%

How did A007575 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

-366%

Payout Ratio

Does A007575 pay a reliable dividends?

See A007575 dividend history and benchmarks

When do you need to buy A007575 by to receive an upcoming dividend?
Ilyang PharmaceuticalLtd dividend dates
Ex Dividend Date	Dec 27 2024
Dividend Pay Date	Apr 21 2025
Days until Ex dividend	32 days
Days until Dividend pay date	147 days